BIO-key International, Inc. (BKYI) Comparison with companies in other sectors?

BIO-key International, Inc. has a share price of 6.85M. You can analyze BIO-key International, Inc. (BKYI) competitors across different market sectors through stock heatmaps.

What are BKYI's NET and operating margins?

BIO-key International, Inc. (BKYI) operating margin is around -0.65, and net profit margin is approximately -0.74 as of the latest reports.

In what way does BKYI's earnings per share (EPS) trend reflect its financial momentum?

BIO-key International, Inc. (BKYI) EPS is -1.93 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for BIO-key International, Inc. is -0.43, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for BIO-key International, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for BIO-key International, Inc. like P/E which is -0.82, P/B which is 0.51, and PEG which is -0.11. Compare them with sector averages to evaluate if the stock is priced fairly.

BIO-key International, Inc.

BKYI•NASDAQ

Industrials

Security & Protection Services

$0.83

$0.003(0.36%)

Fundamental Analysis of BIO-key International, Inc. (BKYI)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.93

P/E Ratio

-0.43

ROE

-1.82%

Net Margin

-0.74%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.71M

Shares OutstandingTotal number of shares issued

$6.85M

Book Value/ShareNet worth per share

$1.60

Revenue/ShareAnnual revenue per share

$1.35

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.93

Net MarginNet income as percentage of revenue

-74.10%

Operating MarginOperating income as percentage of revenue

-65.18%

ROEReturn on shareholders' equity

-181.56%

ROAReturn on total assets

-42.11%

ROCEReturn on capital employed

-53.68%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.86

Cash/ShareCash and equivalents per share

$0.67

FCF YieldFree cash flow as percentage of market cap

-72.33%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BKYIFinancial Ratios Analysis details for BKYI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BKYISector Benchmarking details for BKYI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for BIO-key International, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of BIO-key International, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account BIO-key International, Inc.'s unique business strengths and challenges.

Key Financial Metrics for BIO-key International, Inc.

For BIO-key International, Inc., essential financial indicators include EPS -1.93, PE -0.43, and ROE -1.82. These key ratios reveal insights into BIO-key International, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare BIO-key International, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of BIO-key International, Inc.

Metrics like Net Margin -74.10% and ROA -42.11% shed light on how well BIO-key International, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether BIO-key International, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of BIO-key International, Inc.

Using ratios such as P/B Ratio 0.51 and PEG Ratio -0.11, investors can assess whether BIO-key International, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with BIO-key International, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for BIO-key International, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.009 and Cash Flow $-0.86, provide a snapshot of BIO-key International, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like BIO-key International, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for BIO-key International, Inc.

Investing in BIO-key International, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at BIO-key International, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;